Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs. Since its first biotech investment over thirty years ago, Abingworth has helped young biopharma companies on both sides of the Atlantic turn scientific discoveries into new treatments for patients. They provide not only capital but also the experience and strategic guidance necessary for success.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions